Engineering - Biopharmaceutical Engineering

Pharmaceutical and Biopharmaceutical manufacturing are key sectors in the Irish economy generating over 50 per cent of GDP. This sector has seen continued and sustained success with a number of high-profile investments in recent years providing excellent job opportunities for graduates. The programme and its academic faculty are closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excellence for training and research in bioprocessing.



This MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry. This programme offers an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.

Stage 1 Core Modules

CHEN40020 Principles of Biopharmaceutical Engineering (FT) Autumn 5

CHEN40040 Animal Cell Culture Technology (FT) Autumn 5

CHEN40110 Facility Design and Operation Autumn 5

CHEN40120 Biopharmaceutical Industry Regulation and Management Autumn 5

CHEN40630 Bioanalytical Science for Biopharma Autumn 5

CHEN40770 Data Sci for Biopharm Manufact Autumn 5

CHEN40090 Bioprocessing Laboratory Spring 5

CHEN40460 Downstream Processing Spring 5

CHEN40530 Bioprocess Design Spring 5

CHEN40890 Research Methodology FT Spring 5

CHEN40140 Biopharmaceutical Engineering Project Summer 30



Stage 1 Options - A) Min 2 of:

In the Spring trimester students choose 2 modules:

CHEN40130 Bioprocess Scale-up and Technology Transfer Spring 5

CHEN40860 Gene Ther & Vacc Tech & Proc Spring 5

CHEN40870 GMP Manufact Advan Therapeutic Spring 5

- An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account.



- Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.

https://www.ucd.ie/registry/prospectivestudents/admissions/policiesandgeneralregulations/generalrequirements/minimumenglishlanguagerequirements/



- These are the minimum entry requirements – additional criteria may be requested for some programmes.



You may be eligible for Recognition of Prior Learning (RPL), as UCD recognises formal, informal, and/or experiential learning. RPL may be awarded to gain Admission and/or credit exemptions on a programme. Please visit the UCD Registry RPL web page for further information. Any exceptions are also listed on this webpage.

https://www.ucd.ie/registry/prospectivestudents/admissions/rpl/

Apply online



Who Should Apply?

Full Time option suitable for:

Domestic(EEA) applicants: Yes

International (Non EU) applicants: Yes

1 year full-time.

DELIVERY: On Campus

T070 MEngSc in Biopharmaceutical Engineering Master of Engineering Science Full-Time

Commencing September 2026

Graduate Taught

Career Opportunities

Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production. The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world, such as AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities